Mobile Menu

Search Results

Search results for: WES

Promises and pitfalls of precision medicine clinical trials, now and in the future.

As we move towards an ever more personalised healthcare system, genomics is at the heart of what makes an individual […]

Whole genome, whole exome or panel sequencing in precision oncology clinical trials

With a wealth of genomic technologies rapidly advancing with falling cost, implementing genomics into trials and routine care is becoming […]

Genetics Unzipped podcast: Out Standing In the Field – the highs and lows of genetics fieldwork

In the latest episode of Genetics Unzipped our stay-at-home roving reporter Georgia Mills presenter talks to four researchers who’ve been […]

Interview with CRUK: Promises and pitfalls of precision medicine clinical trials

Ahead of our virtual panel discussion on the promises and pitfalls of precision medicine trials: now and in the future […]

How do you achieve cheaper, faster sequencing?

* The following article is written with excerpts from the second edition of The Sequencing Buyer’s Guide. Download the latest […]

Genetics Unzipped podcast: Stinky breath, superheroes and the ‘perfect genome’ – tackling myths and misconceptions about genomics

In the latest episode of Genetics Unzipped, the Genetics Society podcast, Kat Arney takes a look at some of the common myths and misconceptions surrounding genomics and genetic tests. Are mutations always bad? If you’re more like your mum, does that mean you’ve inherited more of her genes? And is there such a thing as a perfect genome? 

Initiative to improve diagnosis of childhood viral lymphomas using liquid biopsy launched

Researchers hope that the effort will be able to validate liquid biopsy (LB) diagnostic methods for childhood lymphomas that are endemic in the region

Interview with Dr Susie Cooke, Head of Medical Genomics at the Glasgow Precision Oncology Laboratory

Dr Susie Cooke is the Head of Medical Genomics at the Glasgow Precision Oncology Laboratory whose main interest is in facilitating the move of next-generation sequencing into the clinic to help cancer patients.